0001214659-20-008368.txt : 20201002 0001214659-20-008368.hdr.sgml : 20201002 20201002161334 ACCESSION NUMBER: 0001214659-20-008368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buxton Cheryl CENTRAL INDEX KEY: 0001796402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 201220133 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-49824.xml PRIMARY DOCUMENT X0306 4 2020-09-30 0001293310 HUMANIGEN, INC HGEN 0001796402 Buxton Cheryl C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true false false false Common Stock, $0.001 par value 2020-09-30 4 A false 1284 10.64 A 4364 D Humanigen completed a 1-for-5 reverse split of its stock on September 11, 2020. Amounts reflected here give effect to the completion of the reverse stock split. /s/ Cameron Durrant, Attorney-In-Fact 2020-10-02